171 related articles for article (PubMed ID: 31308438)
1. Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM).
Ferguson R; Archambault A; Simpson D; Morales L; Chat V; Kazlow E; Lax R; Yoon G; Moran U; Shapiro R; Pavlick A; Polsky D; Osman I; Kirchhoff T
Sci Rep; 2019 Jul; 9(1):10173. PubMed ID: 31308438
[TBL] [Abstract][Full Text] [Related]
2. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
[TBL] [Abstract][Full Text] [Related]
3. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
[TBL] [Abstract][Full Text] [Related]
4. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
5. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.
Kricker A; Armstrong BK; Goumas C; Thomas NE; From L; Busam K; Kanetsky PA; Gallagher RP; Marrett LD; Groben PA; Gruber SB; Anton-Culver H; Rosso S; Dwyer T; Berwick M;
JAMA Dermatol; 2013 Aug; 149(8):921-7. PubMed ID: 23784017
[TBL] [Abstract][Full Text] [Related]
6. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
Bruno W; Pastorino L; Ghiorzo P; Andreotti V; Martinuzzi C; Menin C; Elefanti L; Stagni C; Vecchiato A; Rodolfo M; Maurichi A; Manoukian S; De Giorgi V; Savarese I; Gensini F; Borgognoni L; Testori A; Spadola G; Mandalà M; Imberti G; Savoia P; Astrua C; Ronco AM; Farnetti A; Tibiletti MG; Lombardo M; Palmieri G; Ayala F; Ascierto P; Ghigliotti G; Muggianu M; Spagnolo F; Picasso V; Tanda ET; Queirolo P; Bianchi-Scarrà G
J Am Acad Dermatol; 2016 Feb; 74(2):325-32. PubMed ID: 26775776
[TBL] [Abstract][Full Text] [Related]
7. Genetic and environmental influences in the development of multiple primary melanoma.
Burden AD; Newell J; Andrew N; Kavanagh G; Connor JM; MacKie RM
Arch Dermatol; 1999 Mar; 135(3):261-5. PubMed ID: 10086446
[TBL] [Abstract][Full Text] [Related]
8. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
Auroy S; Avril MF; Chompret A; Pham D; Goldstein AM; Bianchi-Scarrà G; Frebourg T; Joly P; Spatz A; Rubino C; Demenais F; Bressac-de Paillerets B;
Genes Chromosomes Cancer; 2001 Nov; 32(3):195-202. PubMed ID: 11579459
[TBL] [Abstract][Full Text] [Related]
9. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
10. Role of the CDKN2A locus in patients with multiple primary melanomas.
Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of and risk factors for multiple primary melanomas.
Ferrone CR; Ben Porat L; Panageas KS; Berwick M; Halpern AC; Patel A; Coit DG
JAMA; 2005 Oct; 294(13):1647-54. PubMed ID: 16204664
[TBL] [Abstract][Full Text] [Related]
12. Single versus multiple primary melanomas: old questions and new answers.
Hwa C; Price LS; Belitskaya-Levy I; Ma MW; Shapiro RL; Berman RS; Kamino H; Darvishian F; Osman I; Stein JA
Cancer; 2012 Sep; 118(17):4184-92. PubMed ID: 22246969
[TBL] [Abstract][Full Text] [Related]
13. Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011).
Grossman D; Farnham JM; Hyngstrom J; Klapperich ME; Secrest AM; Empey S; Bowen GM; Wada D; Andtbacka RHI; Grossmann K; Bowles TL; Cannon-Albright LA
J Am Acad Dermatol; 2018 Aug; 79(2):238-244. PubMed ID: 29499295
[TBL] [Abstract][Full Text] [Related]
14. Disease Progression in Cases of Multiple Primary Melanoma.
Buljan M; Tomić Sremec N; Sremec J; Tomas D; Crnaric I; Šitum M
Acta Dermatovenerol Croat; 2015; 23(4):260-4. PubMed ID: 26724877
[TBL] [Abstract][Full Text] [Related]
15. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
16. Potential risk factors, clinicopathological features and determinants of survival for multiple primary melanoma patients compared to single primary melanoma: a large single-center Italian study.
Mattavelli I; Patuzzo R; Galeone C; Pelucchi C; Gallino G; Leva A; Valeri B; Santinami M; Maurichi A
Melanoma Res; 2023 Aug; 33(4):309-315. PubMed ID: 37162530
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
[TBL] [Abstract][Full Text] [Related]
18. Multiple primary melanoma revisited.
Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
Dalmasso B; Pastorino L; Ciccarese G; Andreotti V; Grillo F; Mastracci L; Spagnolo F; Ballestrero A; Queirolo P; Bruno W; Ghiorzo P
J Am Acad Dermatol; 2019 May; 80(5):1263-1271. PubMed ID: 30274933
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
Nikolaou V; Kang X; Stratigos A; Gogas H; Latorre MC; Gabree M; Plaka M; Njauw CN; Kypreou K; Mirmigi I; Stefanaki I; Tsao H
Br J Dermatol; 2011 Dec; 165(6):1219-22. PubMed ID: 21801156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]